Skip to main content
Clinical Trials/NCT04215835
NCT04215835UnknownPhase 4

Letrozole Pretreatment With Misoprostol for Induction of Abortion In First-Trimester Missed Miscarriage Among Women With One or More Previous Cesarean Deliveries.: A Randomized Controlled Trial

Cairo University0 sites200 target enrollmentStarted: January 5, 2020Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Enrollment
200
Primary Endpoint
induction to abortion time

Study Overview

Brief Summary

This study compares the success rate of letrozole and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy among women with one or more previous cesarean deliveries.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Gestational age less than 64 days gestation (<9 wks).
  • Hemoglobin >10 g/dL.
  • BMI between 18.5 kg/m2 and 25 kg/m
  • Missed abortion.
  • previous one or more cesarean delivaries

Exclusion Criteria

  • Molar pregnancy.
  • Fibroid uterus.
  • Uterine anomalies.
  • Coagulopathy.
  • Medical disorder that contraindicate induction of abortion (e.g. heart failure).
  • Previous attempts for induction of abortion in the current pregnancy.
  • Allergy to misoprostol or letrozole.

Arms & Interventions

study group

Experimental

3 tablets of Letrozole 2.5 mg will be given as single daily dose, 7.5 mg per day for two days at home and the third dose will be given on admission to hospital on day 3 and will be followed by vaginal misoprostol 800 mcg every three hours up to maximum two doses.

Intervention: letrozole then misoprostol (Drug)

control group

Placebo Comparator

three tablets of placebo will be given as a single daily dose, for two days at home and will be admitted on day 3 and continue treatment with misoprostol 800 mcg every three hours up to maximum two doses

Intervention: placebo then misoprostol (Drug)

Outcomes

Primary Outcomes

induction to abortion time

Time Frame: 6 hours

induction to abortion time

Incidence of complete miscarriage

Time Frame: 6 hours

Incidence of complete miscarriage

Secondary Outcomes

  • Need for surgical evacuation of the products of conception(6 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Samy aly ashour

assistant professor obstetrics and gynecology

Cairo University

Similar Trials